Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1.
While it’s not unusual for certain positions to turn over with a new administration, the number of senior-level FDA staffers ...
The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.
The US drug regulator has missed a deadline for granting full approval to Novavax's COVID-19 vaccine, the company said ...
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results